World Alliance Forum in San Francisco - Healthcare Game Changers: "Emerging Trends and Technologies"

Oct 11, 2019


Come hear from the leaders of innovative American & Japanese biotechnological organizations, and network with top researchers, investors, and policy-makers. 


Tuesday & Wednesday
October 29-30, 2019
9:00 AM - 5:00 PM (PST)

Golden Gate Club
135 Fisher Loop
San Francisco, CA 94129
Google Map

General: $995.00
**Early Bird (til 10/15): $895.00
Academic researchers: $400.00
Students & Postdoc: $150.00

Please contact Kellie La at for a discount code.



The forum’s goal is to build an ecosystem for technologies and policies that enable every person to live a healthy life until his/her last moment.


This year’s 2019 WAFSF US-Japan Global Conference will call for groups within the biomedical, life sciences, biochemistry, governmental organizations and other fields to come together to discuss advanced new medical technologies as well as unmet healthcare needs. The forum also aims to bring together various scientists and business persons with the potential for creative collaboration in shared problem solving and business partnerships.



Click Here for Up-to-Date Information


Dr. Judy Chou Senior Vice President and Global Head of Biotech; Site Head of Bayer Berkeley CA, Bayer Pharmaceutical
Dr. Ted Goldstein VP Chief AI Officer, Anthem
Dr. Hiroto Izumi Special Advisor to the Prime Minister
Dr. Regis Kelly Director, California Institute for Quantitative Bioscience
Dr. Robert Klein Chairman, Americans for Cures
Dr. Maria T. Millan President & CEO, California Institute for Regenerative Medicine
Dr. Shannon Muir Science Officer, Governor's Office of Planning and Research
Dr. Joseph Panetta President & CEO, Biocom
Dr. Mark Ratain Leon O. Jacobson Professor of Medicine; Director, Center for Personalized Therapeutics, University of Chicago
Dr. Jonathan Thomas Chairman, California Institute for Regenerative Medicine
Dr. Tomoki Todo Professor, Division of Innovative Cancer Therapy and Department of Surgical
Neuro-Oncology, The Institute of Medical Science, The University of Tokyo
Dr. Patrick Yang Former EVP of Technical Operations, Juno Therapeutics, Roche and Genentech

Alliance Forum Foundation (AFF)